François Paris Selected Research

O-acetyl-GD2 ganglioside

1/2017	Targeting O-Acetyl-GD2 Ganglioside for Cancer Immunotherapy.
6/2013	Cell cycle arrest and apoptosis induced by O-acetyl-GD2-specific monoclonal antibody 8B6 inhibits tumor growth in vitro and in vivo.
1/2011	A monoclonal antibody to O-acetyl-GD2 ganglioside and not to GD2 shows potent anti-tumor activity without peripheral nervous system cross-reactivity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

François Paris Research Topics

Disease

28	Neoplasms (Cancer) 01/2022 - 02/2007
6	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 01/2013
5	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 07/2016
5	Hypoxia (Hypoxemia) 01/2020 - 01/2013
4	Glioma (Gliomas) 01/2020 - 03/2015
3	Neuroblastoma 01/2022 - 01/2011
2	Lung Neoplasms (Lung Cancer) 01/2020 - 07/2016
2	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2016 - 05/2005
2	medullary Thyroid cancer 04/2010 - 02/2010
1	Erythema 10/2022
1	Obesity 10/2022
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Lung Diseases (Lung Disease) 01/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Niemann-Pick Diseases (Niemann Pick Disease) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2020
1	Intestinal Failure 01/2020
1	Vascular Remodeling 10/2019
1	Neuralgia (Stump Neuralgia) 01/2017
1	Premature Aging 01/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2017
1	Neoplasm Metastasis (Metastasis) 01/2016
1	Colorectal Neoplasms (Colorectal Cancer) 01/2016
1	Pain (Aches) 01/2014
1	Hyperalgesia 01/2014
1	Fibrosarcoma 11/2010
1	Carcinoma (Carcinomatosis) 11/2010
1	Carcinogenesis 11/2010
1	Leukopenia 04/2010
1	Thrombocytopenia (Thrombopenia) 04/2010
1	Weight Loss (Weight Reduction) 02/2010
1	Cytopenia 02/2010
1	Thyroid Neoplasms (Thyroid Cancer) 02/2010

Drug/Important Bio-Agent (IBA)

11	Monoclonal AntibodiesIBA 01/2022 - 09/2007
4	GD2 gangliosideIBA 01/2020 - 09/2007
4	AntigensIBA 01/2017 - 09/2007
3	CeramidesIBA 01/2020 - 02/2007
3	O-acetyl-GD2 gangliosideIBA 01/2017 - 01/2011
2	EnzymesIBA 01/2022 - 01/2017
2	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 01/2020 - 01/2013
2	DesminIBA 01/2020 - 01/2013
2	dinutuximabIBA 01/2017 - 01/2014
2	DNA-Activated Protein KinaseIBA 05/2016 - 01/2016
2	globotriaosylceramide (globotriosylceramide)IBA 04/2013 - 01/2012
2	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 04/2010 - 02/2010
2	Carcinoembryonic AntigenIBA 04/2010 - 02/2010
1	taxaneIBA 10/2022
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022
1	neodymium pyrocatechin disulfonate (NPD)IBA 01/2021
1	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 01/2021
1	AcidsIBA 01/2021
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 11/2020
1	pimonidazoleIBA 01/2020
1	Glutamine (L-Glutamine)FDA Link 01/2020
1	SphingolipidsIBA 01/2020
1	NestinIBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	CarbonIBA 01/2020
1	Temozolomide (Temodar)FDA LinkGeneric 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2019
1	fluoromisonidazoleIBA 02/2018
1	respiratory complex IIIBA 01/2017
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2017
1	GangliosidesIBA 01/2017
1	GlycolipidsIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 07/2016
1	Transcription Factors (Transcription Factor)IBA 07/2016
1	Kruppel-Like Factor 4IBA 07/2016
1	DNA (Deoxyribonucleic Acid)IBA 05/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2016
1	Proteins (Proteins, Gene)FDA Link 05/2016
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 05/2016
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2016
1	Epidermal Growth Factor (EGF)IBA 03/2015
1	Dinoprostone (PGE2)FDA Link 03/2015
1	AntibodiesIBA 01/2014
1	Dextrans (Dextran)FDA Link 01/2013
1	dactolisibIBA 01/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2010
1	MethylcholanthreneIBA 11/2010
1	3- mercapto- 3,3- cyclopentamethylenepropionic acidIBA 11/2010
1	Type 2 Angiotensin ReceptorIBA 11/2010
1	Angiogenesis InhibitorsIBA 04/2010
1	Thalidomide (Thalomid)FDA Link 04/2010
1	Pharmaceutical PreparationsIBA 04/2010
1	Growth InhibitorsIBA 04/2010
1	Bevacizumab (Avastin)FDA Link 02/2010
1	Iodine-131IBA 02/2010
1	Complement System Proteins (Complement)IBA 09/2007
1	Phosphotransferases (Kinase)IBA 05/2005
1	dihydroceramide desaturaseIBA 05/2005

Therapy/Procedure

10	Radiotherapy 01/2020 - 01/2013
7	Immunotherapy 01/2022 - 09/2007
5	Therapeutics 01/2022 - 04/2010
2	Radioimmunotherapy 04/2010 - 02/2010
1	Subcutaneous Injections 01/2020
1	Drug Therapy (Chemotherapy) 10/2019